Possible prognostic impact of WT1 mRNA expression at day + 30 after haploidentical peripheral blood stem cell transplantation with posttransplant cyclophosphamide for patients with myeloid neoplasm: a multicenter study from the Okayama Hematological Study Group.

Wataru KitamuraNobuharu FujiiYuichiro NawaKeigo FujishitaHiroyuki SugiuraTakanori YoshiokaYuki FujiwaraYoshiaki UsuiKeiko FujiiHideaki FujiwaraNoboru AsadaHisakazu NishimoriKen-Ichi MatsuokaYoshinobu Maeda

Published in: International journal of hematology (2022)

The appropriate cutoff level of WT1 mRNA at day + 30 after allo-HSCT for predicting prognosis in patients treated with PTCY-haplo may be < 50 copies/μg RNA.

Keyphrases

stem cell transplantation
high dose
peripheral blood
low dose
bone marrow
acute myeloid leukemia
dendritic cells
low grade
binding protein
nucleic acid
cord blood